UBS Group AG - THERAPEUTICS ACQUISITION COR ownership

Quarter-by-quarter ownership
UBS Group AG ownership history of THERAPEUTICS ACQUISITION COR
ValueSharesWeighting
Q2 2021$5,000
-89.6%
509
-88.8%
0.00%
Q1 2021$48,000
+269.2%
4,525
+377.3%
0.00%
Q4 2020$13,0009480.00%
Other shareholders
THERAPEUTICS ACQUISITION COR shareholders Q3 2021
NameSharesValueWeighting ↓
Foresite Capital Management V, LLC 350,000$4,872,0003.61%
Bain Capital Life Sciences Investors, LLC 1,000,000$13,920,0000.87%
Boxer Capital, LLC 1,500,000$20,880,0000.67%
Logos Global Management LP 500,000$6,960,0000.60%
Foresite Capital Management IV, LLC 350,000$4,872,0000.53%
BVF INC/IL 954,996$13,322,0000.52%
SILVERARC CAPITAL MANAGEMENT, LLC 39,009$543,0000.32%
Avoro Capital Advisors LLC 1,000,000$13,950,0000.24%
Perceptive Advisors 1,500,000$20,880,0000.22%
Cormorant Asset Management, LP 500,000$6,975,0000.17%
View complete list of THERAPEUTICS ACQUISITION COR shareholders